These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2552347)

  • 41. Alpha 2-adrenergic, kappa-opiate, and P1-purinergic autoreceptors have mutually antagonistic effects: a new regulatory mechanism?
    Adamson P; Mantzouridis T; Xiang JZ; Hajimohammadreza I; Brammer MJ; Campbell IC
    J Neurochem; 1989 Oct; 53(4):1077-82. PubMed ID: 2570125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The mu, kappa and delta properties of various opioid agonists.
    Takemori AE; Ikeda M; Portoghese PS
    Eur J Pharmacol; 1986 Apr; 123(3):357-61. PubMed ID: 3013652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation by muscarine and opioid receptors of acetylcholine release in slices from striato-striatal grafts in the rat.
    Wichmann T; Starke K
    Brain Res; 1990 Mar; 510(2):296-302. PubMed ID: 2158852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of selective opiate antagonists on striatal acetylcholine and dopamine release.
    Sandor NT; Lendvai B; Vizi ES
    Brain Res Bull; 1992; 29(3-4):369-73. PubMed ID: 1327422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH; Gulati A; Bhargava HN
    Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of rat cerebral cortical opiate receptors following chronic desimipramine treatment.
    Reisine T; Soubrie P
    Eur J Pharmacol; 1982 Jan; 77(1):39-44. PubMed ID: 6277652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory actions of opioid compounds on calcium fluxes and neurotransmitter release from mammalian cerebral cortical slices.
    Bradford HF; Crowder JM; White EJ
    Br J Pharmacol; 1986 May; 88(1):87-93. PubMed ID: 2871885
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.
    Clark JA; Liu L; Price M; Hersh B; Edelson M; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):461-8. PubMed ID: 2553920
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The specific opioid kappa-agonist U-50,488H inhibits low Km GTPase.
    Ueda H; Misawa H; Fukushima N; Takagi H
    Eur J Pharmacol; 1987 Jun; 138(1):129-32. PubMed ID: 3040426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
    Capasso A; Sorrentino L; Pinto A
    Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of opioid antagonists on acetylcholine release from guinea-pig brain slices: influence of peptidase inhibition.
    Siniscalchi A; Bertelli MG; Bianchi C; Beani L
    Pharmacol Res; 1990; 22(4):493-501. PubMed ID: 2402481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonopioid actions of the kappa-opioid receptor agonists, U 50488H and U 69593 on electrophysiologic properties of hippocampal CA3 neurons in vitro.
    Alzheimer C; ten Bruggencate G
    J Pharmacol Exp Ther; 1990 Nov; 255(2):900-5. PubMed ID: 1978733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opiate receptor agonists regulate phosphorylation of synapsin I in cocultures of rat spinal cord and dorsal root ganglion.
    Nah SY; Saya D; Barg J; Vogel Z
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4052-6. PubMed ID: 8097883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of naloxone on opioid-induced inhibition and facilitation of acetylcholine release in brain slices.
    Beani L; Bianchi C; Siniscalchi A
    Br J Pharmacol; 1982 Jul; 76(3):393-401. PubMed ID: 7104516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic opiate agonists down-regulate prodynorphin gene expression in rat brain.
    Romualdi P; Lesa G; Ferri S
    Brain Res; 1991 Nov; 563(1-2):132-6. PubMed ID: 1786525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opposing effects of oxytocin and of a mu-receptor agonistic opioid peptide on the same class of non-pyramidal neurones in rat hippocampus.
    Raggenbass M; Wuarin JP; Gähwiler BH; Dreifuss JJ
    Brain Res; 1985 Oct; 344(2):392-6. PubMed ID: 2994843
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different profile of electrocortical power spectrum changes after micro-infusion into the locus coeruleus of selective agonists at various opioid receptor subtypes in rats.
    Bagetta G; De Sarro GB; Sakurada S; Rispoli V; Nisticò G
    Br J Pharmacol; 1990 Nov; 101(3):655-61. PubMed ID: 1963804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparative studies on the affinities of K-II and U-50488H for kappa opiate receptor].
    Li JG; Ma SC; Lu SN; Wang CQ
    Yao Xue Xue Bao; 1991; 26(1):10-4. PubMed ID: 1653514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the excitatory amino acid receptor-mediated release of [3H]acetylcholine from rat striatal slices.
    Lehmann J; Scatton B
    Brain Res; 1982 Dec; 252(1):77-89. PubMed ID: 6129033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.